Agios Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Agios Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Agios Pharmaceuticals Inc
Access all reports
Agios Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company's lead product candidate for metabolic diseases is AG-126, which is in Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis. Agios is also developing novel orally available drugs to improve statin responses in patients with hypercholesterolemia and mixed dyslipidemia. The company has collaborations with Amgen Inc., Boehringer Ingelheim, GlaxoSmithKline Plc, Roche Holding AG, Sanofi SA, and Pfizer Inc.; and Abbott Laboratories. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Key slides for Agios Pharmaceuticals Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Agios Pharmaceuticals Inc
Q1 2023
Agios Pharmaceuticals Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States